Abstract:Although arsenic trioxide (As(2)O(3)) induces apoptosis in a relatively wide spectrum of tumors, the sensitivity of different cell types to this treatment varies to a great extent. Because reactive oxygen species (ROS) are critically involved in As(2)O(3)-induced apoptosis, we attempted to explore the possibility that elevating the cellular ROS level might be an approach to facilitate As(2)O(3)-induced apoptosis. Emodin, a natural anthraquinone derivative, was selected because its semiquinone structure is likely to increase the generation of intracellular ROS. Its independent and synergistic effects with As(2)O(3) in cytotoxicity were studied, and the plausible signaling mechanism was investigated in HeLa cells. Cell Proliferation Assay and flow cytometry were used to assess cell viability and apoptosis. Electrophoretic mobility shift assay, luciferase reporter assay, and Western blotting were performed to analyze signaling alteration. The results demonstrated that coadministration of emodin, at low doses of 0.5-10 micro M, with As(2)O(3) enhanced As(2)O(3)-rendered cytotoxicity on tumor cells, whereas these treatments caused no detectable proproliferative or proapoptotic effects on nontumor cells. ROS generation was increased, and activation of nuclear factor kappaB and activator protein 1 was suppressed by coadministration. All enhancements by emodin could be abolished by the antioxidant N-acetyl-L-cysteine. Therefore, we concluded that emodin sensitized HeLa cells to As(2)O(3) via generation of ROS and ROS-mediated inhibition on two major prosurvival transcription factors, nuclear factor kappaB and activator protein 1. This result allows us to propose a novel strategy in chemotherapy that uses mild ROS generators to facilitate apoptosis-inducing drugs whose efficacy depends on ROS.

Involvement of PPARγ in Emodin-Induced HK-2 Cell Apoptosis

Involvement of PI3K/Akt, ERK and P38 Signaling Pathways in Emodin-Mediated Extrinsic and Intrinsic Human Hepatoblastoma Cell Apoptosis

Induction of Apoptosis in Human Renal Tubular Epithelial HK-2 Cells by Emodin and Mediation of Endoplasmic Reticulum Stress

Emodin-provoked Oxidative Stress Induces Apoptosis in Human Colon Cancer HCT116 Cells Through a P53-Mitochondrial Apoptotic Pathway.

Emodin Promotes Apoptosis of Human Endometrial Cancer Through Regulating the MAPK and PI3K/ AKT Pathways

Participation of Cathepsin B in Emodin-Induced Apoptosis in HK-2 Cells

Emodin Targets Mitochondrial Cyclophilin D to Induce Apoptosis in HepG2 Cells.

Emodin regulates apoptotic pathway in human liver cancer cells.

The endoplasmic reticulum stress response is involved in apoptosis induced by aloe-emodin in HK-2 cells

Inhibition of Mitochondrial Complex Function-The Hepatotoxicity Mechanism of Emodin Based on Quantitative Proteomic Analyses

Emodin Induces Human T Cell Apoptosis in Vitro by ROS-mediated Endoplasmic Reticulum Stress and Mitochondrial Dysfunction

Emodin Enhances Arsenic Trioxide-Induced Apoptosis Via Generation of Reactive Oxygen Species and Inhibition of Survival Signaling

NMR-based Metabolomic Techniques Identify the Toxicity of Emodin in HepG2 Cells

Emodin Inhibits LPS-induced Inflammatory Response by Activating PPAR-γ in Mouse Mammary Epithelial Cells.

CYP3A Activation and Glutathione Depletion Aggravate Emodin-Induced Liver Injury.

[Emodin Induces Apoptosis of Cancer Cells and Inhibits Retinoid X Receptor Transcriptional Activity].

Emodin Induces Apoptosis of Lung Cancer Cells Through ER Stress and the TRIB3/NF-κB Pathway.

Emodin Induces Apoptotic Death in Murine Myelomonocytic Leukemia WEHI-3 Cells in Vitro and Enhances Phagocytosis in Leukemia Mice in Vivo.

Inhibition effect of emodin on human gastric carcinoma cell line MKN45 and its molecular mechanism

Anticancer Effects of Emodin on HepG2 Cell: Evidence from Bioinformatic Analysis

Emodin Inhibits the Growth of Hepatoma Cells: Finding the Common Anti-Cancer Pathway Using Huh7, Hep3B, and HepG2 Cells.